Loading...

Novartis AG

NVSEF•PNK
Healthcare
Drug Manufacturers - General
$111.38
$-4.62(-3.98%)

Novartis AG (NVSEF) Financial Performance & Income Statement Overview

Analyze Novartis AG (NVSEF) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.

Revenue Growth
10.85%
↑ 10.85%
Operating Income Growth
48.88%
↑ 48.88%
Net Income Growth
-19.59%
↓ 19.59%
Operating Cash Flow Growth
21.86%
↑ 21.86%
Operating Margin
29.78%
↑ 29.78%
Gross Margin
75.40%
↑ 75.40%
Net Profit Margin
24.40%
↑ 24.40%
ROE
30.86%
↑ 30.86%
ROIC
23.09%
↑ 23.09%

Novartis AG (NVSEF) Income Statement & Financial Overview

View the income breakdown for Novartis AG NVSEF across both annual and quarterly reports.

MetricQ1 2025Q4 2024Q3 2024Q2 2024
Revenue$13.62B$13.56B$13.17B$12.87B
Cost of Revenue$3.23B$3.32B$3.23B$3.17B
Gross Profit$10.39B$10.23B$9.94B$9.70B
Gross Profit Ratio$0.76$0.75$0.75$0.75
R&D Expenses$2.37B$2.84B$2.39B$2.37B
SG&A Expenses$3.06B$3.50B$3.13B$3.09B
Operating Expenses$5.73B$6.70B$6.31B$5.68B
Total Costs & Expenses$8.96B$10.03B$9.54B$8.86B
Interest Income$0.00$291.00M$26.00M$246.00M
Interest Expense$0.00$275.00M$264.00M$246.00M
Depreciation & Amortization$1.09B$1.63B$1.97B$1.16B
EBITDA$5.75B$5.19B$5.61B$5.25B
EBITDA Ratio$0.42$0.38$0.43$0.41
Operating Income$4.66B$3.53B$3.63B$4.01B
Operating Income Ratio$0.34$0.26$0.28$0.31
Other Income/Expenses (Net)-$256.00M-$245.00M-$242.00M-$173.00M
Income Before Tax$4.41B$3.29B$3.38B$3.84B
Income Before Tax Ratio$0.32$0.24$0.26$0.30
Income Tax Expense$798.00M$465.00M$200.00M$595.00M
Net Income$3.61B$2.82B$3.19B$3.25B
Net Income Ratio$0.26$0.21$0.24$0.25
EPS$1.83$1.40$1.58$1.60
Diluted EPS$1.82$1.39$1.57$1.59
Weighted Avg Shares Outstanding$1.97B$1.99B$2.01B$2.04B
Weighted Avg Shares Outstanding (Diluted)$1.98B$2.004B$2.03B$2.05B

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;